Pals ST - Search Results

1

Growth factors in multiple myeloma: a comprehensive analysis of their expression in tumor cells and bone marrow environment using Affymetrix microarrays.

Mahtouk K, Moreaux J, Hose D, Rème T, Meissner T, Jourdan M, Rossi JF, Pals ST, Goldschmidt H, Klein B. Mahtouk K, et al. Among authors: pals st. BMC Cancer. 2010 May 13;10:198. doi: 10.1186/1471-2407-10-198. BMC Cancer. 2010. PMID: 20465808 Free PMC article.

2

The HGF/MET pathway as target for the treatment of multiple myeloma and B-cell lymphomas.

Mahtouk K, Tjin EP, Spaargaren M, Pals ST. Mahtouk K, et al. Among authors: pals st. Biochim Biophys Acta. 2010 Dec;1806(2):208-19. doi: 10.1016/j.bbcan.2010.07.006. Epub 2010 Jul 22. Biochim Biophys Acta. 2010. PMID: 20655987 Review.

3

Transcriptional silencing of the Wnt-antagonist DKK1 by promoter methylation is associated with enhanced Wnt signaling in advanced multiple myeloma.

Kocemba KA, Groen RW, van Andel H, Kersten MJ, Mahtouk K, Spaargaren M, Pals ST. Kocemba KA, et al. Among authors: pals st. PLoS One. 2012;7(2):e30359. doi: 10.1371/journal.pone.0030359. Epub 2012 Feb 17. PLoS One. 2012. PMID: 22363428 Free PMC article.

4

The hypoxia target adrenomedullin is aberrantly expressed in multiple myeloma and promotes angiogenesis.

Kocemba KA, van Andel H, de Haan-Kramer A, Mahtouk K, Versteeg R, Kersten MJ, Spaargaren M, Pals ST. Kocemba KA, et al. Among authors: pals st. Leukemia. 2013 Aug;27(8):1729-37. doi: 10.1038/leu.2013.76. Epub 2013 Mar 12. Leukemia. 2013. PMID: 23478664

5

Studies of bone and soft-tissue tumours induced in rats with radioactive cerium chloride.

Klein B, Pals S, Masse R, Lafuma J, Morin M, Binart N, Jasmin JR, Jasmin C. Klein B, et al. Int J Cancer. 1977 Jul 15;20(1):112-9. doi: 10.1002/ijc.2910200118. Int J Cancer. 1977. PMID: 269099

6

N-cadherin-mediated interaction with multiple myeloma cells inhibits osteoblast differentiation.

Groen RW, de Rooij MF, Kocemba KA, Reijmers RM, de Haan-Kramer A, Overdijk MB, Aalders L, Rozemuller H, Martens AC, Bergsagel PL, Kersten MJ, Pals ST, Spaargaren M. Groen RW, et al. Among authors: pals st. Haematologica. 2011 Nov;96(11):1653-61. doi: 10.3324/haematol.2010.038133. Epub 2011 Aug 9. Haematologica. 2011. PMID: 21828122 Free PMC article.

7

The hepatocyte growth factor/Met pathway controls proliferation and apoptosis in multiple myeloma.

Derksen PW, de Gorter DJ, Meijer HP, Bende RJ, van Dijk M, Lokhorst HM, Bloem AC, Spaargaren M, Pals ST. Derksen PW, et al. Among authors: pals st. Leukemia. 2003 Apr;17(4):764-74. doi: 10.1038/sj.leu.2402875. Leukemia. 2003. PMID: 12682635

8

Deletion of the WNT target and cancer stem cell marker CD44 in Apc(Min/+) mice attenuates intestinal tumorigenesis.

Zeilstra J, Joosten SP, Dokter M, Verwiel E, Spaargaren M, Pals ST. Zeilstra J, et al. Among authors: pals st. Cancer Res. 2008 May 15;68(10):3655-61. doi: 10.1158/0008-5472.CAN-07-2940. Cancer Res. 2008. PMID: 18483247

9

Heparan sulfate proteoglycans in the control of B cell development and the pathogenesis of multiple myeloma.

Reijmers RM, Spaargaren M, Pals ST. Reijmers RM, et al. Among authors: pals st. FEBS J. 2013 May;280(10):2180-93. doi: 10.1111/febs.12180. Epub 2013 Mar 4. FEBS J. 2013. PMID: 23419151 Free article. Review.

10

The CXCL12gamma chemokine immobilized by heparan sulfate on stromal niche cells controls adhesion and mediates drug resistance in multiple myeloma.

Ren Z, Lantermans H, Kuil A, Kraan W, Arenzana-Seisdedos F, Kersten MJ, Spaargaren M, Pals ST. Ren Z, et al. Among authors: pals st. J Hematol Oncol. 2021 Jan 12;14(1):11. doi: 10.1186/s13045-021-01031-3. J Hematol Oncol. 2021. PMID: 33436043 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

249 results

Search Page

Filters